|
Real-time Estimate
Cboe BZX
22:34:19 22/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.225 USD | +9.37% |
|
+12.39% | -65.30% |
| 08-14 | ADC Therapeutics Balances LOTIS-5 Regulatory Risk With LOTIS-7 Opportunity, RBC Says | MT |
| 08-13 | ADC Therapeutics SA, Q2 2026 Earnings Call, Aug 13, 2026 |
| Market Cap | 143M 125M 117M 107M 201M 13.67B 201M 1.41B 544M 6.98B 537M 525M 22.5B | P/E 2026 * |
-1.47x | P/E 2027 * | -1.65x |
|---|---|---|---|---|---|
| Enterprise Value | 143M 125M 117M 107M 201M 13.67B 201M 1.41B 544M 6.98B 537M 525M 22.5B | EV / Sales 2026 * |
1.77x | EV / Sales 2027 * | 1.4x |
| Free-Float |
83.9% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ADCT | Delayed | |
CBOE
| ADCT | Real-time |
Last Transcript: ADC Therapeutics SA
| 1 day | +9.38% | ||
| 1 week | +12.39% | ||
| Current month | +4.70% | ||
| 1 month | +26.93% | ||
| 3 months | +12.39% | ||
| 6 months | -69.75% | ||
| Current year | -65.30% |
| 1 week | 1.01 |  | 1.25 |
| 1 month | 0.95 | | 1.37 |
| Current year | 0.78 | | 4.98 |
| 1 year | 0.78 | | 4.98 |
| 3 years | 0.36 | | 6.04 |
| 5 years | 0.36 | | 32 |
| 10 years | 0.36 | | 56.59 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ameet Mallik
CEO | Chief Executive Officer | 53 | 09/05/2022 |
Jose Carmona
DFI | Director of Finance/CFO | 54 | 19/12/2022 |
David Ege
CTO | Chief Tech/Sci/R&D Officer | 52 | 01/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Hug
BRD | Director/Board Member | 67 | 01/06/2019 |
Tyrell Rivers
BRD | Director/Board Member | 53 | 01/06/2018 |
Ron Squarer
CHM | Chairman | 59 | 01/03/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/06/26 | Free | Chief Executive Officer | 675,000 | 0.5307% | ||
| 30/06/26 | Free | Chief Financial Officer | 203,700 | 0.1602% | ||
| 30/06/26 | Free | Chief Technology Officer | 213,900 | 0.1682% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.37% | +12.39% | -64.80% | +70.16% | 143M | |
| -0.07% | +5.66% | +54.34% | +113.69% | 74.33B | |
| -1.45% | -0.40% | +35.52% | +79.18% | 62.26B | |
| -0.66% | +7.14% | +39.36% | +29.20% | 27.72B | |
| -0.16% | +0.58% | -16.83% | +360.91% | 26.42B | |
| +3.54% | +4.62% | +2.47% | -3.33% | 24.62B | |
| +0.84% | +6.00% | +25.53% | -9.89% | 20.72B | |
| +0.87% | -2.52% | +151.81% | +328.17% | 15.01B | |
| +2.33% | +2.86% | +47.88% | +172.49% | 14.18B | |
| +1.12% | -1.32% | -10.10% | +818.18% | 13.48B | |
| Average | +1.60% | +0.75% | +26.52% | +195.88% | 27.89B | |
| Weighted average by Cap. | +0.20% | +2.10% | +36.93% | +150.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 80.65M 70.48M 66.24M 60.45M 113M 7.71B 113M 795M 307M 3.94B 303M 296M 12.69B | 102M 89.11M 83.75M 76.43M 143M 9.75B 143M 1.01B 388M 4.98B 383M 375M 16.05B |
| Net income | -120M -105M -98.45M -89.84M -169M -11.46B -169M -1.18B -456M -5.85B -450M -440M -18.87B | -118M -103M -96.72M -88.26M -166M -11.26B -166M -1.16B -448M -5.75B -442M -433M -18.53B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/09/26 | $1.225 | +9.38% | 1,111,145 |
| 21/09/26 | $1.120 | +6.67% | 1,899,275 |
| 18/09/26 | $1.050 | -0.94% | 1,580,274 |
| 17/09/26 | $1.060 | +0.95% | 1,545,569 |
| 16/09/26 | $1.050 | -3.67% | 3,316,970 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADCT Stock
Select your edition
All financial news and data tailored to specific country editions
